Background: To retrospectively evaluate the difference in terms of pathologic complete response (pCR) according to time elapsed between chemoradiation (CRT) and total mesorectal excision (TME) on a large unselected real-life dataset of locally advanced rectal cancer (LARC) patients. Methods: A multicentre retrospective cohort study of LARC patients from 21 Italian Radiotherapy Institutions was performed. Patients were stratified into 3 different time intervals from CRT. The 1st group included 300 patients who underwent TME within 6 weeks, the 2nd 1598 patients (TME within 7\u201312 weeks) and the 3rd 196 patients (TME within 13 or more weeks after CRT), respectively. Results: Data on 2094 LARC patients treated between 1997 and 2016 were con...
The French Research Group of Rectal Cancer Surgery (GRECCAR)International audienceBackground: Neoadj...
Neoadjuvant therapy is the gold standard treatment of locally advanced rectal cancer. It may induce ...
Background: The optimal timing of surgery in relation to chemoradiation is still controversial. Retr...
Background: To retrospectively evaluate the difference in terms of pathologic complete response (pCR...
Aim The aim was to compare the pathological complete response (pCR) rate at 8 compared to 12 weeks' ...
Contains fulltext : 171843pub.pdf (publisher's version ) (Open Access)BACKGROUND: ...
International audiencePurpose A pathologic complete response (pCR; ypT0N0) of a rectal tumor after n...
WOS: 000444672600005PubMed ID: 30155949Background: The optimal timing of surgery following preoperat...
Aims: The aim of this study was to define a potential benefit of pathological complete response rate...
Introduction: Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (...
The French Research Group of Rectal Cancer Surgery (GRECCAR)International audienceBackground: Neoadj...
Neoadjuvant therapy is the gold standard treatment of locally advanced rectal cancer. It may induce ...
Background: The optimal timing of surgery in relation to chemoradiation is still controversial. Retr...
Background: To retrospectively evaluate the difference in terms of pathologic complete response (pCR...
Aim The aim was to compare the pathological complete response (pCR) rate at 8 compared to 12 weeks' ...
Contains fulltext : 171843pub.pdf (publisher's version ) (Open Access)BACKGROUND: ...
International audiencePurpose A pathologic complete response (pCR; ypT0N0) of a rectal tumor after n...
WOS: 000444672600005PubMed ID: 30155949Background: The optimal timing of surgery following preoperat...
Aims: The aim of this study was to define a potential benefit of pathological complete response rate...
Introduction: Patients with locally advanced rectal cancer (LARC) who are unfit for chemoradiation (...
The French Research Group of Rectal Cancer Surgery (GRECCAR)International audienceBackground: Neoadj...
Neoadjuvant therapy is the gold standard treatment of locally advanced rectal cancer. It may induce ...
Background: The optimal timing of surgery in relation to chemoradiation is still controversial. Retr...